Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy

by Kevin McLaughlin PharmD, BCPS, Jessica Rimsans PharmD, BCPS, Katelyn W. Sylvester PharmD, BCPS, CACP, John Fanikos Rph, MBA, David M. Dorfman MD, PhD, Patricia Senna MT, ASCP, Jean M. Connors MD, Samuel Z. Goldhaber MD
Published 2019-09-01